Freenome, every mention
18 scenes · ← back to Freenome
tap a year for its mentions
every year anyone Vijay Pande 12Sonal Chokshi 2Gabriel Ott 2Frank Chen 2Ben Horowitz 2Jorge Conde 1
Verbatim, from the transcripts: the passages where Freenome comes up
Healthcare Has Left the Building
- ▶ 13:50 unnamed speaker Companies like Freenome are using artificial intelligence to make the next generation of diagnostics.
AI is Industrializing Discovery
- ▶ 7:05 Vijay Pande And so a great example, this is a company called Freenum.
a16z Podcast | Revisiting the Gene
- ▶ 0:27 Sonal Chokshi Includes Carlos Araya, co-founder and CEO of Jungla, and Gabe Ott, co-founder and CEO of Freenome, and was moderated by A-Six-Teen-Z general partner Jorge Conde.
- ▶ 7:09 Gabriel Ott What we're looking at at Freenome is that dynamic DNA, uh, as assayed from our, uh, blood sample
- ▶ 10:50 Jorge Conde So look, thinking about Freenome, you know, perhaps this is unfair comparison or an example, but if we think about early screening, we've been using mammograms for 3040 years, and the data suggests that while we've actually done a lot of…
a16z Podcast | Taking the Pulse on Bio
- ▶ 1:29 Vijay Pande So a great example of this is something like Freenome, where you take genomics, and the data from what the DNA in your blood tells you about your immune system.
- ▶ 14:02 Vijay Pande Like Freenome or Cardiogram in these diagnostic spaces where as each of them gets more data, they get more accurate.
a16z Podcast | When Will Genomics Live Up to the Hype?
- ▶ 0:35 unnamed speaker This episode was recorded at our inaugural summit, moderated by A-Six-Teen Z's Malinka Walaliate, and joined by Carlos Araya from Jungla, Jeff Kaditz from Q, and Gabe Ott from Freenome. 2 times in the scene
a16z Podcast | On the Genomics of Disease, From Science to Business
- ▶ 0:03 Sonal Chokshi I'm Sonal, and I'm here today with Gabriel Ott, who is the co-founder and CEO of Freenome, which is a company that aims to cure cancer through early detection using machine learning and other software techniques on DNA.
- ▶ 15:38 Gabriel Ott I mean, I think one of the most inspiring things as I've been building a freenome is hearing the personal stories of not only the employees, but my friends who have been all been touched by cancer in some way, shape or form.
When Biology Moves to Engineering
- ▶ 7:59 Vijay Pande And what we're seeing is companies like Freenome that look for the signals for cancer from blood can do considerably better.
- ▶ 22:50 Vijay Pande And so if you think about the game plan that Freenome runs for taking blood and understanding where there's cancer and what's the cancerous agents in there, what BioAge is doing is doing essentially the same thing, looking at the blood of…
On Career Moves and Business Leadership
- ▶ 38:14 Ben Horowitz You know, we're invested in a company called Freenome, which uses kind of machine learning against biology to diagnose cancer. 2 times in the scene
The Promise of AI
- ▶ 29:28 Frank Chen The company Freenome is working on a cancer diagnostic by reading the DNA that's free floating in your bloodstream. 2 times in the scene
On Machine Learning in Medicine and More
- ▶ 2:28 Vijay Pande So a company like Freenome will use machine learning and deep learning with genomics to be able to tell whether you have cancer early enough, such that the cure rate, success rate could be 80%, a hundred percent.
- ▶ 5:26 Vijay Pande So a great example of this is the Freenome co-founder, Gabe, who has a PhD in biology, and I asked him, ah, what deep learning code he's using, as of all the many variants, he said, I'm using the one I wrote.
- ▶ 9:23 Vijay Pande Yeah, you could take a company like Omada, which has, uh, this therapy for pre-diabetics, or a company like Freenome, which has the cancer therapy. 2 times in the scene
- ▶ 11:57 Vijay Pande Yeah, I think, you know, I'm very excited about this recent investment we've done in Freenome. 3 times in the scene